MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-19-0117064
Vetfar Pharmaceuticals Private Limited
Vetfar Pharmaceuticals Private Limited - chemicals and materials in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹16.11 Cr
▲ 532% YoY
Net loss · FY 2025
₹86 Lakh
Net margin -5.3%
EBITDA · FY 2025
₹2.15 Cr
EBITDA margin 13.3%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹9.99 Cr
Issued & subscribed
Open charges
₹17.6 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
About Vetfar Pharmaceuticals Private Limited
Data last updated:
Vetfar Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 21 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2021PTC366147. Its GSTIN is 27AAICV2320B1ZS (Maharashtra).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.99 Cr. It is led by directors Rahul Jayant Nachane and Rajesh Narayan Lawande.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 401 Gopal Vishnu Vile Parle East 31 Mahant Road Opp Ruia School, Mumbai, Maharashtra, India – 400057.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.11 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹86 Lakh (net margin -5.3%) and EBITDA of ₹2.15 Cr (EBITDA margin 13.3%).
As per MCA filings, the company has open charges of ₹17.6 Cr on record. The company has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹7.65 Cr; the latest was in March 2022. Its 7 peer companies in the Chemicals industry (Industrial Chemicals, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 5 smaller; the largest is U-Tech Fabric Private Limited with revenue of ₹16.24 Cr.
Vetfar Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-19-0117064).
Company details
CIN U24299MH2021PTC366147
Registration Number 366147
Incorporation Date 21 August 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification MSME
Udyam Registration UDYAM-MH-19-0117064
Recognitions & Rankings of Vetfar Pharmaceuticals
Contact details
Vetfar Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address401 Gopal Vishnu Vile Parle East 31 Mahant Road Opp Ruia School, Mumbai, Maharashtra, India – 400057
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Vetfar Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Vetfar Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Vetfar Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vetfar Pharmaceuticals Private Limited, buy the company report.
Financials of Vetfar Pharmaceuticals Private Limited
FY 2025 filings availableVetfar Pharmaceuticals Private Limited reported revenue of ₹16.11 Cr (up 532% YoY) for FY 2025.
Revenue · FY 2025
₹16.11 Cr ▲ 532%
Net loss · FY 2025
₹86 Lakh margin -5.3%
EBITDA · FY 2025
₹2.15 Cr margin 13.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 532%
EBITDA CAGR growth
1 year
▲ 438%
3 years · compounded
▲ 579%
Revenue rose 532% in the latest year. EBITDA rose 438% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹2.15 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹86 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 13.3% | |||
| Net Profit Margin | -5.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Vetfar Pharmaceuticals Private Limited, buy the company report.
Board of directors of Vetfar Pharmaceuticals Private Limited
Vetfar Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Jayant Nachane Also directs: NGL Fine-Chem Limited, Macrotech Polychem Private Limited, Nupur Remedies Pvt Ltd and 1 more | Director | 21 Aug 2021 | 5 Years 2 Months | Current |
| Rajesh Narayan Lawande | Director | 21 Aug 2021 | 5 Years 2 Months | Current |
Peer comparison
Vetfar Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Chemicals industry (Industrial Chemicals, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| U-Tech Fabric Private Limited | ₹16.24 Cr (FY 2024) | 155.0% | Kolkata, West Bengal, India | |||
| Polo Pharmaceuticals Private Limited | ₹16.12 Cr (FY 2025) | 18.0% | Himachal Pradesh, India | |||
| Vetfar Pharmaceuticals Private Limitedthis company | ₹16.11 Cr (FY 2025) | -₹86 Lakh | -5.3% | 532.0% | Mumbai, Maharashtra, India | |
| Mia Plasticizer and Allied Products Private Limited | ₹16.1 Cr (FY 2025) | -12.0% | Delhi, India | |||
| Vertex Chem Private Limited | ₹16.09 Cr (FY 2025) | 38.0% | Kalyan, Maharashtra, India | |||
| Caprica Lifetech Private Limited | ₹16.08 Cr (FY 2025) | 4675.0% | Sanand, Gujarat, India | |||
| Chemical Udyog Private Limited | ₹16.08 Cr (FY 2025) | 21.0% | Rourkela, Odisha, India | |||
| Machhar Industries Limited | ₹16.08 Cr (FY 2025) | -7.0% | Aurangabad, Maharashtra, India |
To see the full peer comparison of Vetfar Pharmaceuticals Private Limited, buy the company report.
Auditor
Vetfar Pharmaceuticals Private Limited is audited by BHARAT GANDHI & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHARAT GANDHI & CO. | FY 2023 | 101214W |
Shareholding
The shareholding of Vetfar Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Vetfar Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹17.6 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Jan 2023 | 100736659 | Hdfc Bank Limited | ₹17.6 Cr | Open |
Total charge records: 1 View all charges
Deals & funding
Vetfar Pharmaceuticals Private Limited has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹7.65 Cr; the latest was in March 2022.
Total deals
2
Rights issue
1
Funding round
1
Disclosed funding
₹7.65 Cr
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Rights issue | ₹1.34 Cr | Investors: Nupur Remedies Pvt Ltd , 2 individuals |
| Jan 2022 | Funding round | ₹7.65 Cr | Investors: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Vetfar Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vetfar Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vetfar Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 03, 2024.
Active EPFO establishments
1
GST
Vetfar Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICV2320B1ZS | Maharashtra | Active | 09 Sep 2021 |
To see the full GST registrations and return filing status of Vetfar Pharmaceuticals Private Limited, buy the company report.
Recent activity
Vetfar Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Rahul Jayant Nachane was appointed as Director on 21 Aug 2021.
AGM
Vetfar Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vetfar Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 17.60 Cr with Charge ID 100736659 was registered on 16 Jan 2023.
Appointed
Rahul Jayant Nachane was appointed as Director.
Appointed
Rajesh Narayan Lawande was appointed as Director.
Incorporation
21 Aug 2021
Vetfar Pharmaceuticals Private Limited was registered on 21 Aug 2021 with Roc Mumbai I & aged 5 years 2 months as per MCA records.
Frequently asked questions
Vetfar Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 21 August 2021 (5+ years old) and is registered under CIN U24299MH2021PTC366147.
Vetfar Pharmaceuticals has 2 current directors:
- Rahul Jayant Nachane - Director
- Rajesh Narayan Lawande - Director
The latest financial statements of Vetfar Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Vetfar Pharmaceuticals is 27AAICV2320B1ZS, registered in Maharashtra.
The CIN (Corporate Identification Number) of Vetfar Pharmaceuticals is U24299MH2021PTC366147. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vetfar Pharmaceuticals was incorporated on 21 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Vetfar Pharmaceuticals has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹7.65 Cr; the latest was in March 2022.
The peers of Vetfar Pharmaceuticals by revenue are U-Tech Fabric Private Limited, Polo Pharmaceuticals Private Limited, Mia Plasticizer and Allied Products Private Limited, Vertex Chem Private Limited, Caprica Lifetech Private Limited and 2 more, all in the Chemicals industry (Industrial Chemicals, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rahul Jayant Nachane was appointed as Director on 21 Aug 2021. Rajesh Narayan Lawande was appointed as Director on 21 Aug 2021.
Yes, Vetfar Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-MH-19-0117064).
The registered office of Vetfar Pharmaceuticals is at 401 Gopal Vishnu Vile Parle East 31 Mahant Road Opp Ruia School, Mumbai, Maharashtra, India – 400057.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages